Clinical Trial

Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508C and YHR2603 in healthy subjects
Trial Details
NCT Number NCT07584304
Lead Sponsor Yuhan Corporation
Conditions Healthy Subjects
Enrollment 44 participants
Start Date 2026-07-10
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-13